Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program
Rev. esp. quimioter
; 35(Supl. 3): 102-107, Oct. 2022. ilus
Article
em En
| IBECS
| ID: ibc-210759
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
The current morbimortality of serious infections is unacceptable and there is a need to promote the increase in the efficacy of empirical and targeted antibiotherapy. This could be achieved by initiatives coming from ASP teams aimed at promoting increased efficacy of antibiotic therapy .In the optimization of the antibiotic therapy there are several critical points in which an adequate timing could achieve benefits in the survival of patients with severe infections prompt initiation of empirical treatment; de-escalation performance, appropriate targeted treatment; and finally, curtail antibiotic duration. (AU)
Palavras-chave
Texto completo:
1
Base de dados:
IBECS
Assunto principal:
Bactérias
/
Anti-Infecciosos
/
Antibacterianos
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article